Related Experiment Video
Updated: Oct 10, 2025
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Boosting Cancer Immunotherapy via the Convenient A2AR Inhibition Using a Tunable Nanocatalyst with Light-Enhanced
Wenqian Yu1, Junlin Sun1, Xiuyuan Wang1
1Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Abstract:
Blockade of A2A adenosine receptors (A2AR)-adenosinergic signaling shows high potency to mobilize antitumor immunity for its in-depth involvement in immune regulation of nearly all immune cells. Available A2AR inhibition strategies are mainly based on small molecules or proteins inhibitors, yet are limited by the non-specific operation as well as the off-target toxicity. Herein, the first effort to design a convenient tumor-specific A2AR inhibition strategy to improve antitumor immune responses via the spatiotemporally controlled oxygen supply by virtue of a versatile photo-modulated nanoreactor is reported on. This nanoreactor, consisting of a catalase-mimicking shell (Pt nanocatalyst) and a photothermal core (polydopamine), is rationally designed for achieving the near-infrared radiation (NIR)-guided/accelerated oxygen supplementation on tumor site, and for relieving the A2AR-mediated immunosuppression without toxicity concern. Meanwhile, the NIR light could also mediate the direct photothermal ablation of tumor, and elicit immunogenic cell deaths to boost antitumor immunity. In a poorly immunogenic breast cancer model, the intravenous injection of the nanoreactor leads to the improved immune response with an increased animal survival rate, and achieves the long-term immunological memory effect against tumor recurrence as well as rechallenge. This convenient nanoreactor-stimulated A2AR inhibition approach provides a versatile promising paradigm for improving these existing immunotherapies.
Insights
This study introduces a novel nanoreactor that uses near-infrared light to specifically block adenosine A2A receptors (A2AR) in tumors. This approach enhances antitumor immunity and survival rates, offering a promising new cancer immunotherapy strategy.
Area of Science:
- Immunology
- Nanotechnology
- Biomedical Engineering
Background:
- Adenosine A2A receptor (A2AR) signaling plays a crucial role in regulating antitumor immunity.
- Current A2AR inhibition strategies often suffer from non-specific action and off-target toxicity.
- Developing tumor-specific inhibition methods is essential for effective cancer immunotherapy.
Purpose of the Study:
- To design a novel, tumor-specific nanoreactor for spatiotemporally controlled oxygen supply to inhibit A2AR.
- To leverage near-infrared (NIR) radiation for guided and accelerated oxygen release at the tumor site.
- To enhance antitumor immune responses and reduce immunosuppression without causing toxicity.
Main Methods:
- A photo-modulated nanoreactor was engineered with a catalase-mimicking platinum nanocatalyst shell and a polydopamine photothermal core.
- The nanoreactor was designed for NIR-guided oxygen supplementation and A2AR inhibition.
- NIR light was used for both photothermal tumor ablation and to trigger oxygen release.
- The nanoreactor's efficacy was evaluated in a poorly immunogenic breast cancer model.
Main Results:
- The nanoreactor successfully delivered oxygen to the tumor site, relieving A2AR-mediated immunosuppression.
- NIR irradiation facilitated tumor ablation and induced immunogenic cell death.
- Intravenous injection of the nanoreactor significantly improved antitumor immune responses and increased animal survival rates.
- A long-term immunological memory effect against tumor recurrence and rechallenge was observed.
Conclusions:
- The developed nanoreactor provides a convenient and tumor-specific strategy for A2AR inhibition.
- This approach effectively enhances antitumor immunity and offers a promising paradigm for improving existing cancer immunotherapies.
- The dual-action capability of photothermal ablation and targeted immunosuppression blockade presents a versatile therapeutic strategy.
Related Concept Videos
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...